• Company
• CSL Behring’s hemophilia B Tx Idelvion is reimbursed in KOR
• by Kang, Hye-Kyung Jul 3, 2024 05:50am

• Company
• Daewoong and LG Chem launch Humira biosimilar 'Xelenka'
• by Kim, Jin-Gu Jul 3, 2024 05:50am

• Company
• Hugel signs distribution partnership agreement with Benev
• by Nho, Byung Chul Jul 2, 2024 05:49am

• Company
• PNH drug Voydeya is approved…new treatment option for PNH
• by Hwang, Byung-woo Jul 2, 2024 05:49am

• Opinion
• [Reporter’s View] 'all-comers' with strict criteria
• by Eo, Yun-Ho Jul 2, 2024 05:48am

• Policy
• GSK will discontinue supply of Infanrix IPV
• by Lee, Tak-Sun Jul 2, 2024 05:48am

• Company
• GLP-1 uses↑…targets MASH, diabetes, and obesity
• by Son, Hyung-Min Jul 1, 2024 05:48am

• Company
• Companies to focus on developing trispecific antibodies
• by Son, Hyung-Min Jul 1, 2024 05:48am

• Company
• Various treatment options introduced for multiple myeloma
• by Eo, Yun-Ho Jul 1, 2024 05:48am

• Company
• Samsung Bioepis targets Stelara market
• by Hwang, Byung-woo Jul 1, 2024 05:47am